The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
COVID-19 and Cancer: Current Challenges and Perspectives
Open accessAbstract
Patients with cancer have been disproportionately affected by the COVID-19 pandemic. This effect has included the adverse outcomes in patients with cancer who develop COVID-19, the impact of the COVID-19 pandemic on the delivery of cancer care, and the severe disruption to cancer research. However, patients with cancer are a heterogeneous population, and recent studies have now documented factors that allow risk stratification of patients with cancer in order to optimize care. In this review, we highlight data at the intersection of COVID-19 and cancer, including the biological interplay between the two diseases and practical recommendations for the treatment of patients with cancer during the pandemic. We additionally discuss the potential long-lasting impact of the pandemic on cancer care due to its deleterious effect on cancer research, as well as biological insights from the cancer research community that could help develop novel therapies for all patients with COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Oncology meets immunology: the cancer-immunity cycle.
Chen, D. S., & Mellman, I. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.012 · Cited by 6,929
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674
Endothelial cell infection and endotheliitis in COVID-19
Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30937-5 · Cited by 6,358
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., Vanstapel, A., Werlein, C., Stark, H., Tzankov, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015432 · Cited by 5,613
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., et al. (2020) · JAMA · doi:10.1001/jama.2020.5394 · Cited by 5,469
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
Klok, F. A., Kruip, M. J. H. A., van der Meer, N. J. M., Arbous, M. S., Gommers, D. A. M. P. J., Kant, K. M., Kaptein, F. H. J., van Paassen, J., Stals, M. A. M., Huisman, M. V., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.013 · Cited by 5,028
Detection of SARS-CoV-2 in Different Types of Clinical Specimens
Wang, W., Xu, Y., Gao, R., Lu, R., Han, K., Wu, G., & Tan, W. (2020) · JAMA · doi:10.1001/jama.2020.3786 · Cited by 5,028
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Postow, M. A., Sidlow, R., & Hellmann, M. D. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1703481 · Cited by 4,849
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K., Li, C., Ai, Q., Lu, W., Liang, H., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30096-6 · Cited by 4,384
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Waldman, A. D., Fritz, J. M., & Lenardo, M. J. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0306-5 · Cited by 4,154
Ou, X., Liu, Y., Lei, X., Li, P., Mi, D., Ren, L., Guo, L., Guo, R., Chen, T., Hu, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15562-9 · Cited by 3,097
Wynants, L., Van Calster, B., Bonten, M. M., Collins, G. S., Debray, T. P., De Vos, M., Haller, M. C., Heinze, G., Moons, K. G., Riley, R. D., et al. (2020) · doi:10.1101/2020.03.24.20041020 · Cited by 3,070
Virtually perfect? Telemedicine for COVID-19
Hollander, J. E., & Carr, B. G. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2003539 · Cited by 2,970
An inflammatory cytokine signature predicts COVID-19 severity and survival
Del Valle, D. M., Kim-Schulze, S., Huang, H.-H., Beckmann, N. D., Nirenberg, S., Wang, B., Lavin, Y., Swartz, T. H., Madduri, D., Stock, A., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1051-9 · Cited by 2,605
COVID-19 and its implications for thrombosis and anticoagulation
Connors, J. M., & Levy, J. H. (2020) · Blood · doi:10.1182/blood.2020006000 · Cited by 2,369
Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
Sharma, P., & Allison, J. P. (2015) · Cell · doi:10.1016/j.cell.2015.03.030 · Cited by 2,345
Ziegler, C. G. K., Allon, S. J., Nyquist, S. K., Mbano, I. M., Miao, V. N., Tzouanas, C. N., Cao, Y., Yousif, A. S., Bals, J., Hauser, B. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.035 · Cited by 2,284
Cummings, M. J., Baldwin, M. R., Abrams, D., Jacobson, S. D., Meyer, B. J., Balough, E. M., Aaron, J. G., Claassen, J., Rabbani, L. E., Hastie, J., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31189-2 · Cited by 2,212
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Lucas, C., Wong, P., Klein, J., Castro, T. B. R., Silva, J., Sundaram, M., Ellingson, M. K., Mao, T., Oh, J. E., Israelow, B., et al. (2020) · Nature · doi:10.1038/s41586-020-2588-y · Cited by 2,074
Thrombosis as an intravascular effector of innate immunity
Engelmann, B., & Massberg, S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3345 · Cited by 1,989
COVID-19 and African Americans
Yancy, C. W. (2020) · JAMA · doi:10.1001/jama.2020.6548 · Cited by 1,934
Maringe, C., Spicer, J., Morris, M., Purushotham, A., Nolte, E., Sullivan, R., Rachet, B., & Aggarwal, A. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30388-0 · Cited by 1,807
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Kuderer, N. M., Choueiri, T. K., Shah, D. P., Shyr, Y., Rubinstein, S. M., Rivera, D. R., Shete, S., Hsu, C.-Y., Desai, A., de Lima Lopes, G., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31187-9 · Cited by 1,726
Self-citationShimabukuro-Vornhagen, A., Gödel, P., Subklewe, M., Stemmler, H. J., Schlößer, H. A., Schlaak, M., Kochanek, M., Böll, B., & von Bergwelt-Baildon, M. S. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0343-9 · Cited by 1,656
Dai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z., Zhang, Z., You, H., Wu, M., Zheng, Q., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0422 · Cited by 1,589
Ferrario, C. M., Jessup, J., Chappell, M. C., Averill, D. B., Brosnihan, K. B., Tallant, E. A., Diz, D. I., & Gallagher, P. E. (2005) · Circulation · doi:10.1161/circulationaha.104.510461 · Cited by 1,565
Immunological effects of conventional chemotherapy and targeted anticancer agents
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.10.012 · Cited by 1,530
Swann, J. B., & Smyth, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31405 · Cited by 1,447
Laboratory Diagnosis of COVID-19: Current Issues and Challenges
Tang, Y.-W., Schmitz, J. E., Persing, D. H., & Stratton, C. W. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00512-20 · Cited by 1,232
High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients
Llitjos, J., Leclerc, M., Chochois, C., Monsallier, J., Ramakers, M., Auvray, M., & Merouani, K. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14869 · Cited by 1,206
Cytokines in clinical cancer immunotherapy
Berraondo, P., Sanmamed, M. F., Ochoa, M. C., Etxeberria, I., Aznar, M. A., Pérez-Gracia, J. L., Rodríguez-Ruiz, M. E., Ponz-Sarvise, M., Castañón, E., & Melero, I. (2019) · British Journal of Cancer · doi:10.1038/s41416-018-0328-y · Cited by 1,205
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
Arabi, Y. M., Mandourah, Y., Al-Hameed, F., Sindi, A. A., Almekhlafi, G. A., Hussein, M. A., Jose, J., Pinto, R., Al-Omari, A., Kharaba, A., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201706-1172oc · Cited by 1,122
Lee, L. Y., Cazier, J.-B., Angelis, V., Arnold, R., Bisht, V., Campton, N. A., Chackathayil, J., Cheng, V. W., Curley, H. M., Fittall, M. W., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31173-9 · Cited by 1,103
Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples
Bullard, J., Dust, K., Funk, D., Strong, J. E., Alexander, D., Garnett, L., Boodman, C., Bello, A., Hedley, A., Schiffman, Z., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa638 · Cited by 1,075
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
Yu, J., Ouyang, W., Chua, M. L. K., & Xie, C. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.0980 · Cited by 1,071
Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence
Poissy, J., Goutay, J., Caplan, M., Parmentier, E., Duburcq, T., Lassalle, F., Jeanpierre, E., Rauch, A., Labreuche, J., Susen, S., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.047430 · Cited by 1,071
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Guaraldi, G., Meschiari, M., Cozzi-Lepri, A., Milic, J., Tonelli, R., Menozzi, M., Franceschini, E., Cuomo, G., Orlando, G., Borghi, V., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30173-9 · Cited by 939
Tuckson, R. V., Edmunds, M., & Hodgkins, M. L. (2017) · New England Journal of Medicine · doi:10.1056/nejmsr1503323 · Cited by 907
Le, R. Q., Li, L., Yuan, W., Shord, S. S., Nie, L., Habtemariam, B. A., Przepiorka, D., Farrell, A. T., & Pazdur, R. (2018) · The Oncologist · doi:10.1634/theoncologist.2018-0028 · Cited by 873
Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China
Mo, P., Xing, Y., Xiao, Y., Deng, L., Zhao, Q., Wang, H., Xiong, Y., Cheng, Z., Gao, S., Liang, K., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa270 · Cited by 853
Interactive telemedicine: effects on professional practice and health care outcomes
Flodgren, G., Rachas, A., Farmer, A. J., Inzitari, M., & Shepperd, S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002098.pub2 · Cited by 806
Argenziano, M. G., Bruce, S. L., Slater, C. L., Tiao, J. R., Baldwin, M. R., Barr, R. G., Chang, B. P., Chau, K. H., Choi, J. J., Gavin, N., et al. (2020) · BMJ · doi:10.1136/bmj.m1996 · Cited by 791
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
Mehta, V., Goel, S., Kabarriti, R., Cole, D., Goldfinger, M., Acuna-Villaorduna, A., Pradhan, K., Thota, R., Reissman, S., Sparano, J. A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0516 · Cited by 765
Venous Thromboembolism and Cancer: Risks and Outcomes
Lee, A. Y. Y., & Levine, M. N. (2003) · Circulation · doi:10.1161/01.cir.0000078466.72504.ac · Cited by 721
Racial health disparities and covid-19 - caution and context
Chowkwanyun, M., & Reed, A. L. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2012910 · Cited by 706
Cytokine storms: understanding COVID-19
Mangalmurti, N., & Hunter, C. A. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.017 · Cited by 698
An interferon‐γ‐related cytokine storm in SARS patients
Huang, K., Su, I., Theron, M., Wu, Y., Lai, S., Liu, C., & Lei, H. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20255 · Cited by 679
Lee, N., Allen Chan, K. C., Hui, D. S., Ng, E. K. O., Wu, A., Chiu, R. W. K., Wong, V. W. S., Chan, P. K. S., Wong, K. T., Wong, E., et al. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.07.006 · Cited by 636
Determinants of COVID-19 disease severity in patients with cancer
Robilotti, E. V., Babady, N. E., Mead, P. A., Rolling, T., Perez-Johnston, R., Bernardes, M., Bogler, Y., Caldararo, M., Figueroa, C. J., Glickman, M. S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0979-0 · Cited by 628
Teachey, D. T., Rheingold, S. R., Maude, S. L., Zugmaier, G., Barrett, D. M., Seif, A. E., Nichols, K. E., Suppa, E. K., Kalos, M., Berg, R. A., et al. (2013) · Blood · doi:10.1182/blood-2013-02-485623 · Cited by 613
Garassino, M. C., Whisenant, J. G., Huang, L.-C., Trama, A., Torri, V., Agustoni, F., Baena, J., Banna, G., Berardi, R., Bettini, A. C., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30314-4 · Cited by 612
Self-citationLee, L. Y. W., Cazier, J.-B., Starkey, T., Briggs, S. E. W., Arnold, R., Bisht, V., Booth, S., Campton, N. A., Cheng, V. W. T., Collins, G., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30442-3 · Cited by 574
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic
Sud, A., Jones, M. E., Broggio, J., Loveday, C., Torr, B., Garrett, A., Nicol, D. L., Jhanji, S., Boyce, S. A., Gronthoud, F., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.05.009 · Cited by 552
Coagulation and cancer: biological and clinical aspects
FALANGA, A., MARCHETTI, M., & VIGNOLI, A. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12075 · Cited by 551
Passamonti, F., Cattaneo, C., Arcaini, L., Bruna, R., Cavo, M., Merli, F., Angelucci, E., Krampera, M., Cairoli, R., Della Porta, M. G., et al. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30251-9 · Cited by 545
Tian, J., Yuan, X., Xiao, J., Zhong, Q., Yang, C., Liu, B., Cai, Y., Lu, Z., Wang, J., Wang, Y., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30309-0 · Cited by 528
COVID-19 in Immunocompromised Hosts: What We Know So Far
Fung, M., & Babik, J. M. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa863 · Cited by 526
Montopoli, M., Zumerle, S., Vettor, R., Rugge, M., Zorzi, M., Catapano, C. V., Carbone, G. M., Cavalli, A., Pagano, F., Ragazzi, E., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.04.479 · Cited by 518
Health and Racial Disparity in Breast Cancer
Yedjou, C. G., Sims, J. N., Miele, L., Noubissi, F., Lowe, L., Fonseca, D. D., Alo, R. A., Payton, M., & Tchounwou, P. B. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-20301-6_3 · Cited by 509
Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19
Somers, E. C., Eschenauer, G. A., Troost, J. P., Golob, J. L., Gandhi, T. N., Wang, L., Zhou, N., Petty, L. A., Baang, J. H., Dillman, N. O., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa954 · Cited by 497
Lucas, J. M., Heinlein, C., Kim, T., Hernandez, S. A., Malik, M. S., True, L. D., Morrissey, C., Corey, E., Montgomery, B., Mostaghel, E., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-1010 · Cited by 468
COVID-19 in persons with haematological cancers
He, W., Chen, L., Chen, L., Yuan, G., Fang, Y., Chen, W., Wu, D., Liang, B., Lu, X., Ma, Y., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0836-7 · Cited by 462
Cao, Y., Wei, J., Zou, L., Jiang, T., Wang, G., Chen, L., Huang, L., Meng, F., Huang, L., Wang, N., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.019 · Cited by 456
Smith, J. C., Sausville, E. L., Girish, V., Yuan, M. L., Vasudevan, A., John, K. M., & Sheltzer, J. M. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.05.012 · Cited by 415
Pinto, B. G. G., Oliveira, A. E. R., Singh, Y., Jimenez, L., Gonçalves, A. N. A., Ogava, R. L. T., Creighton, R., Schatzmann Peron, J. P., & Nakaya, H. I. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa332 · Cited by 391
TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?
Stopsack, K. H., Mucci, L. A., Antonarakis, E. S., Nelson, P. S., & Kantoff, P. W. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0451 · Cited by 382
Hu, F., Lamprecht, M. R., Wei, L., Morrison, B., & Min, W. (2016) · Scientific Reports · doi:10.1038/srep39660 · Cited by 367
Min, C.-K., Cheon, S., Ha, N.-Y., Sohn, K. M., Kim, Y., Aigerim, A., Shin, H. M., Choi, J.-Y., Inn, K.-S., Kim, J.-H., et al. (2016) · Scientific Reports · doi:10.1038/srep25359 · Cited by 364
Garvin, M. R., Alvarez, C., Miller, J. I., Prates, E. T., Walker, A. M., Amos, B. K., Mast, A. E., Justice, A., Aronow, B., & Jacobson, D. (2020) · eLife · doi:10.7554/elife.59177 · Cited by 361
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19
Roschewski, M., Lionakis, M. S., Sharman, J. P., Roswarski, J., Goy, A., Monticelli, M. A., Roshon, M., Wrzesinski, S. H., Desai, J. V., Zarakas, M. A., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd0110 · Cited by 357
Infections in Cancer Patients with Solid Tumors: A Review
Rolston, K. V. I. (2017) · Infectious Diseases and Therapy · doi:10.1007/s40121-017-0146-1 · Cited by 334
Saini, K. S., Tagliamento, M., Lambertini, M., McNally, R., Romano, M., Leone, M., Curigliano, G., & de Azambuja, E. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.08.011 · Cited by 331
Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters
London, J. W., Fazio-Eynullayeva, E., Palchuk, M. B., Sankey, P., & McNair, C. (2020) · JCO Clinical Cancer Informatics · doi:10.1200/cci.20.00068 · Cited by 323
ACE2 of the heart: From angiotensin I to angiotensin (1–7)
KEIDAR, S., KAPLAN, M., & GAMLIELLAZAROVICH, A. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.09.006 · Cited by 278
Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients
Liu, T., Luo, S., Libby, P., & Shi, G.-P. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107587 · Cited by 273
COVID-19 in patients with lung cancer
Luo, J., Rizvi, H., Preeshagul, I. R., Egger, J. V., Hoyos, D., Bandlamudi, C., McCarthy, C. G., Falcon, C. J., Schoenfeld, A. J., Arbour, K. C., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.06.007 · Cited by 267
Oncology Practice During the COVID-19 Pandemic
Schrag, D., Hershman, D. L., & Basch, E. (2020) · JAMA · doi:10.1001/jama.2020.6236 · Cited by 252
Androgen receptor and androgen-dependent gene expression in lung
Mikkonen, L., Pihlajamaa, P., Sahu, B., Zhang, F.-P., & Jänne, O. A. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.12.022 · Cited by 243
Muus, C., Luecken, M. D., Eraslan, G., Waghray, A., Heimberg, G., Sikkema, L., Kobayashi, Y., Vaishnav, E. D., Subramanian, A., Smilie, C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.19.049254 · Cited by 236
Horby, P., Mafham, M., Linsell, L., Bell, J. L., Staplin, N., Emberson, J. R., Wiselka, M., Ustianowski, A., Elmahi, E., Prudon, B., et al. (2020) · medRxiv · doi:10.1101/2020.07.15.20151852 · Cited by 233
Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers
Luo, J., Rizvi, H., Egger, J. V., Preeshagul, I. R., Wolchok, J. D., & Hellmann, M. D. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0596 · Cited by 232
Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient Data
Giannakoulis, V. G., Papoutsi, E., & Siempos, I. I. (2020) · JCO Global Oncology · doi:10.1200/go.20.00225 · Cited by 226
Westblade, L. F., Brar, G., Pinheiro, L. C., Paidoussis, D., Rajan, M., Martin, P., Goyal, P., Sepulveda, J. L., Zhang, L., George, G., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.09.007 · Cited by 217
Price, C. C., Altice, F. L., Shyr, Y., Koff, A., Pischel, L., Goshua, G., Azar, M. M., Mcmanus, D., Chen, S.-C., Gleeson, S. E., et al. (2020) · Chest · doi:10.1016/j.chest.2020.06.006 · Cited by 204
Waterhouse, D. M., Harvey, R. D., Hurley, P., Levit, L. A., Kim, E. S., Klepin, H. D., Mileham, K. F., Nowakowski, G., Schenkel, C., Davis, C., et al. (2020) · JCO Oncology Practice · doi:10.1200/op.20.00275 · Cited by 199
Smith, W. R., Atala, A. J., Terlecki, R. P., Kelly, E. E., & Matthews, C. A. (2020) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2020.04.030 · Cited by 196
Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
Pinato, D. J., Zambelli, A., Aguilar-Company, J., Bower, M., Sng, C. C. T., Salazar, R., Bertuzzi, A., Brunet, J., Mesia, R., Seguí, E., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0773 · Cited by 179
Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study
Ip, A., Berry, D. A., Hansen, E., Goy, A. H., Pecora, A. L., Sinclaire, B., Bednarz, U., Marafelias, M., Berry, S. M., Berry, N., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237693 · Cited by 165
Dissecting racial disparities in multiple myeloma
Marinac, C. R., Ghobrial, I. M., Birmann, B. M., Soiffer, J. L., & Rebbeck, T. R. (2020) · Blood Cancer Journal · doi:10.1038/s41408-020-0284-7 · Cited by 159
Wolters, F., van de Bovenkamp, J. H. B., van den Bosch, B., van den Brink, S., Broeders, M. M. C., Chung, N. H., Favié, B., Goderski, G., Kuijpers, J., Overdevest, I. T. M. A., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104426 · Cited by 148
Oberfeld, B., Achanta, A., Carpenter, K., Chen, P., Gilette, N. M., Langat, P., Said, J. T., Schiff, A. E., Zhou, A. S., Barczak, A. K., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.013 · Cited by 148
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy
Chung, M. K., Karnik, S. S., Saef, J., Bergmann, C. C., Barnard, J., Lederman, M. M., Tilton, J. C., Cheng, F., Harding, C. V., Young, J. B., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102907 · Cited by 140
SAFDAR, A. Y. E. S. H. A., & Armstrong, D. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir492 · Cited by 137
Rivera, D. R. R., Peters, S., Panagiotou, O. A., Shah, D. P., Kuderer, N. M., Hsu, C., Rubinstein, S. M., Lee, B. J., Choueiri, T. K., Lopes, G. D. L., Jr., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0941 · Cited by 137
Self-citationTelemedicine for Cancer Care in the Time of COVID-19
Royce, T. J., Sanoff, H. K., & Rewari, A. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.2684 · Cited by 122
Telemedicine for Cancer Patients During COVID-19 Pandemic: Between Threats and Opportunities
Elkaddoum, R., Haddad, F. G., Eid, R., et al. (2020) · Future Oncology · doi:10.2217/fon-2020-0324 · Cited by 119
Baratchian, M., McManus, J. M., Berk, M. P., Nakamura, F., Mukhopadhyay, S., Xu, W., ERZURUM, S. C., Drazba, J. A., Peterson, J. W., Klein, E. A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90491-1 · Cited by 119
Chen, Y.-Y., Guan, B.-S., Li, Z.-K., & Li, X.-Y. (2018) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x16686777 · Cited by 118
Albiges, L. K., Foulon, S., Bayle, A., Gachot, B., Pommeret, F., Willekens, C., Stoclin, A., Merad-Boudia, M., Griscelli, F., Lacroix, L., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-00120-5 · Cited by 116
Rogado, J., Obispo, B., Pangua, C., et al. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02381-z · Cited by 92
Liu, Y., Chen, Q., Zhang, N., Zhang, K., Dou, T., Cao, Y., Liu, Y., Li, K., Hao, X., Xie, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19579-y · Cited by 92
VTE in ICU Patients With COVID-19
Moll, M. R., Zon, R. L., Sylvester, K. W., Chen, E. C., Cheng, V., Connell, N. T., Fredenburgh, L. E., Baron, R. M., Cho, M. H., Woolley, A. E., et al. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.07.031 · Cited by 89
Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia
Jordan, S. C., Zakowski, P. C., Tran, H. P. N., Smith, E. A., Gaultier, C., Marks, G., Zabner, R., Lowenstein, H., Oft, J. R., Bluen, B. E., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa812 · Cited by 83
Crowdsourcing a crisis response for COVID-19 in oncology
Desai, A. P., Warner, J. L., Kuderer, N. M., Thompson, M., Painter, C., Lyman, G. H., & Lopes, G. D. L., Jr. (2020) · Nature Cancer · doi:10.1038/s43018-020-0065-z · Cited by 80
Self-citationUnger, J. M., Blanke, C. D., LeBlanc, M. L., & Hershman, D. L. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.10651 · Cited by 80
Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study
Schmidt, A. L., Bakouny, Z., Bhalla, S., Steinharter, J. A., Tremblay, D. A., Awad, M. M., Kessler, A. J., Haddad, R. I., Evans, M., Busser, F. J., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.10.023 · Cited by 72
Self-citationDisparities in prostate cancer incidence and mortality rates: Solvable or not?
Badal, S. A. M., Aiken, W. D., Morrison, B. F., Valentine, H., Bryan, S., Gachii, A., & Ragin, C. C. R. (2019) · The Prostate · doi:10.1002/pros.23923 · Cited by 68
Cancer Patient Care during COVID-19
Harky, A., Chiu, C. M., Yau, T., & Lai, S. H. D. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.05.006 · Cited by 67
Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID‐19
Patell, R. D., Bogue, T., Bindal, P., Koshy, A. G., Merrill, M. H., Aird, W. C., Bauer, K. A., & Zwicker, J. I. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15018 · Cited by 64
The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19
Anil, I., Arnold, R. R., Benkwitz-Beford, S., Branford, S., Campton, N. A., Cazier, J., Cheng, V. W. T., Curley, H. M., D'Costa, J., Edmondson, A., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30230-8 · Cited by 60
Survey of the Impact of COVID-19 on Oncologists’ Decision Making in Cancer
Ürün, Y., Hussain, S. A., Bakouny, Z., Castellano, D., Kılıçkap, S., Morgan, G., McKay, R. R., Pels, K., Schmidt, A. L., Doroshow, D. B., et al. (2020) · JCO Global Oncology · doi:10.1200/go.20.00300 · Cited by 58
Self-citationTERAVOLT: Thoracic Cancers International COVID-19 Collaboration
Whisenant, J. G., Trama, A., Torri, V., Toma, A. D., Viscardi, G., Cortellini, A., Michielin, O. A., Barlési, F., Dingemans, A. C., van Meerbeeck, J. P., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.05.008 · Cited by 57
Self-citationDisparities in Cancer Outcomes Due to COVID-19—A Tale of 2 Cities
Balogun, O., Bea, V. J., & Phillips, E. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.3327 · Cited by 54
Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity
Agarwal, V., Venkatakrishnan, A., Puranik, A., Kirkup, C., Lopez-Marquez, A., Challener, D. W., Theel, E. S., O’Horo, J. C., Binnicker, M. J., Kremers, W. K., et al. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00375-y · Cited by 51
Rubinstein, S. M., Steinharter, J. A., Warner, J. L., Rini, B. I., Peters, S., & Choueiri, T. K. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.04.018 · Cited by 48
Self-citationCheckpoint Inhibitor Pneumonitis: Mechanisms, Characteristics, Management Strategies, and Beyond
Reuss, J. E., Suresh, K. S., & Naidoo, J. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-00920-z · Cited by 47
Rethinking Clinical Trials Reform During the COVID-19 Pandemic
Nabhan, C., Choueiri, T. K., & Mato, A. R. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.3142 · Cited by 41
Self-citationChen, Y., Shan, K.-J., & Qian, W. (2020) · Preprints.org · doi:10.20944/preprints202002.0258.v2 · Cited by 39
Sex and Racial Disparities in the Treatment and Outcomes of Muscle-invasive Bladder Cancer
Marinaro, J. A., Zeymo, A., Egan, J. M., et al. (2020) · Urology · doi:10.1016/j.urology.2020.06.087 · Cited by 28
Perspectives on Oncology-Specific Language During the Coronavirus Disease 2019 Pandemic
Gharzai, L. A., Resnicow, K., An, L. C., & Jagsi, R. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.2980 · Cited by 22
Morrison, D. R., Gentile, C. M., McCammon, S. D., & Buczek, E. P. (2020) · Head & Neck · doi:10.1002/hed.26262 · Cited by 20
COVID-19 and haematological malignancy: navigating a narrow strait
Rubinstein, S. M., & Warner, J. L. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30252-0 · Cited by 19
Self-citationDigitalized Adaptation of Oncology Trials during and after COVID-19
Li, G., Yin, C., Zhou, Y., Wang, T., Chen, J., Liu, Y., Chen, T., Wang, H., Zhang, L., & Chen, X. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.018 · Cited by 18
Decrease in ACE2 mRNA expression in aged mouse lungPreprint
Booeshaghi, A. S., & Pachter, L. S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.02.021451 · Cited by 16
TMPRSS2 Transcriptional Inhibition as a Therapeutic Strategy for COVID-19Preprint
Wang, X., Dhindsa, R. S., Povysil, G., Zoghbi, A. W., Motelow, J. E., Hostyk, J. A., Nickols, N., Rettig, M. B., & Goldstein, D. B. (2020) · Preprints.org · doi:10.20944/preprints202003.0360.v2 · Cited by 15
Utility of COVID-19 Screening in Cancer Patients
Lee, L. Y. W., Hill, T. M., Topping, O., Tilby, M., Baker, M. R., Greig, J., Isherwood, L., Miller, R. E., Petrenko, Y., Desai, R., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.07.009 · Cited by 12
Cancer datasets and the SARS-CoV-2 pandemic: establishing principles for collaboration
Palmieri, C., Palmer, D. H., Openshaw, P., Baillie, J. K., Semple, M. G., & Turtle, L. C. W. (2020) · ESMO Open · doi:10.1136/esmoopen-2020-000825 · Cited by 7
Cited by
Seroconversion rates following COVID-19 vaccination among patients with cancer
Thakkar, A., Gonzalez-Lugo, J. D., Goradia, N., Gali, R., Shapiro, L. C., Pradhan, K., Rahman, S., Kim, S. Y., Ko, B., Sica, R. A., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.06.002 · Cited by 344
Grivas, P., Khaki, A. R., Wise-Draper, T. M., French, B., Hennessy, C., Hsu, C.-Y., Shyr, Y., Li, X., Choueiri, T. K., Painter, C. A., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.02.024 · Cited by 309
Self-citation
Metadata
- Authors
- Bakouny, Z., Hawley, J. E., Choueiri, T. K., Peters, S., Rini, B. I., Warner, J. L., & Painter, C. A.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 38
- Issue
- 5
- Pages
- 629-646
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W3090418364
- Cited by
- 275
- References
- 135
- FWCI
- 16.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.